Citius Oncology, Inc. reported a warrant inducement agreement on May 5, 2026, where they induced the exercise of warrants at a reduced price of $0.90 per share, generating approximately $11.5 million for ongoing commercialization efforts. They also announced a new loan agreement for up to $25 million to be used for funding operations and expansion.